Furthermore, several lines of evidence have indicated that plasma concentration of adiponectin is severely decreased in patients with obesity [11], type 2 diabetes, and cardiovascular diseases [12,13]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.